Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) has received an average rating of "Buy" from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $197.50.
Several equities analysts have recently weighed in on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of Sol-Gel Technologies in a research note on Tuesday, September 1st. Zacks Research raised shares of Sol-Gel Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, October 15th. Cantor Fitzgerald started coverage on shares of Sol-Gel Technologies in a report on Wednesday, October 14th. They issued an "overweight" rating for the company. Finally, HC Wainwright restated a "buy" rating and issued a $110.00 price target on shares of Sol-Gel Technologies in a research report on Monday, October 19th.
Read Our Latest Research Report on SLGL
Insider Buying and Selling
In related news, major shareholder Opaleye Management Inc. purchased 35,113 shares of Sol-Gel Technologies stock in a transaction dated Friday, August 28th. The shares were acquired at an average cost of $69.32 per share, with a total value of $2,434,033.16. Following the purchase, the insider owned 520,000 shares of the company's stock, valued at approximately $36,046,400. The trade was a 7.24% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders purchased 53,430 shares of company stock valued at $3,684,739 in the last 90 days. Corporate insiders own 66.51% of the company's stock.
Hedge Funds Weigh In On Sol-Gel Technologies
A hedge fund recently bought a new position in Sol-Gel Technologies stock. Navellier & Associates Inc. purchased a new position in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,785 shares of the company's stock, valued at approximately $429,000. Navellier & Associates Inc. owned about 0.21% of Sol-Gel Technologies at the end of the most recent reporting period. Institutional investors own 26.18% of the company's stock.
Sol-Gel Technologies Stock Performance
NASDAQ:SLGL opened at $54.08 on Friday. The firm's fifty day moving average is $65.46 and its two-hundred day moving average is $73.64. The firm has a market cap of $176.84 million, a price-to-earnings ratio of -10.34 and a beta of 1.25. Sol-Gel Technologies has a one year low of $34.10 and a one year high of $97.97.
Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported ($1.72) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.07) by $0.35. The company had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.15 million. Sol-Gel Technologies had a negative return on equity of 38.80% and a negative net margin of 1,115.39%. As a group, equities research analysts predict that Sol-Gel Technologies will post -5.37 earnings per share for the current fiscal year.
About Sol-Gel Technologies
(
Get Free Report)
Sol-Gel Technologies is an Israel-based dermatology company that develops topical treatments for skin conditions. Its proprietary technology uses silica-based microencapsulation to formulate active ingredients for topical use. The company's products include Epsolay, a benzoyl peroxide cream approved in the United States for inflammatory lesions of rosacea, and Twyneo, a topical combination of tretinoin and benzoyl peroxide approved for acne vulgaris. Sol-Gel has pursued commercialization and licensing opportunities in the United States and other markets.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sol-Gel Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sol-Gel Technologies wasn't on the list.
While Sol-Gel Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.